Pretomanid

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 456 publications

Black hairy tongue: an early adverse effect of linezolid in treatment of multidrug resistant tuberculosis.

Black hairy tongue: an early adverse effect of linezolid in treatment of multidrug resistant tuberculosis.

Journal: BMJ case reports

Published: August 27, 2026

Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

Journal: Microbiology spectrum

Published: August 26, 2026

No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context.

No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context.

Journal: Microbiology spectrum

Published: July 28, 2026

Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in Mycobacterium tuberculosis using TM4::GeNL reporter mycobacteriophages.

Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in Mycobacterium tuberculosis using TM4::GeNL reporter mycobacteriophages.

Journal: Microbiology spectrum

Published: July 15, 2026

In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.

In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: July 13, 2026

Safety evaluation of pretomanid, an anti-tuberculosis drug, for the treatment of pregnant and lactating women.

Safety evaluation of pretomanid, an anti-tuberculosis drug, for the treatment of pregnant and lactating women.

Journal: Antimicrobial agents and chemotherapy

Published: July 10, 2026

Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro.

Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro.

Journal: Microbiology spectrum

Published: July 10, 2026

Chinese guideline for the chemotherapy of multidrug-resistant/rifampicin-resistant tuberculosis (2026 edition)

Chinese guideline for the chemotherapy of multidrug-resistant/rifampicin-resistant tuberculosis (2026 edition)

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: June 03, 2026

Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting.

Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 02, 2026

Differential Regulation of Oxidative Burst by First Line Drugs Used Against Multi Drug-Resistant Tuberculosis in Naïve Human Innate Immune Cells.

Differential Regulation of Oxidative Burst by First Line Drugs Used Against Multi Drug-Resistant Tuberculosis in Naïve Human Innate Immune Cells.

Journal: Antibiotics (Basel, Switzerland)

Published: May 12, 2026

Mechanism of the M. tuberculosis DprE1-DprE2 epimerase complex and inhibition by anti-tubercular drugs.

Mechanism of the M. tuberculosis DprE1-DprE2 epimerase complex and inhibition by anti-tubercular drugs.

Journal: Nature chemical biology

Published: May 09, 2026

Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors.

Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

Showing 1-12 of 456

Last Updated: 09/26/2026